Unscheduled Hospital Readmission After Crenel Lateral Interbody Fusion

The goal of this observational study is to learn about the readmission related to Crenel Lateral Interbody Fusion (CLIF). The main question it aims to answer is:

What are the risk factors for readmission after CLIF surgery?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spine Degeneration

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310000, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with spinal degeneration undergoing CLIF surgery

Exclusion criteria

Under the age of 18

Treatment and study plan

Crenel Lateral Interbody Fusion

Procedure

The Crenel Lateral Interbody Fusion (CLIF) is a surgical technique developed by the Department of Spine Surgery at the Second Affiliated Hospital of Zhejiang University School of Medicine. Building on the traditional Lateral Lumbar Interbody Fusion technique, this series of technical improvements overcomes the shortcomings of previous surgical methods, enhancing the safety, operability, and effectiveness of the surgery while reducing complications.

Other names: Lateral Lumbar Interbody Fusion

Crenel lateral interbody fusion plus second stage surgery

Procedure

The patient was first admitted to undergo CLIF surgery and was discharged after the operation. The patient will return to the hospital for a second surgery at the scheduled time.

Primary outcomes

Unscheduled readmission

Time frame: 1 year

Unscheduled readmission refers to a patient who was unplanned or unexpected return to the hospital after CLIF discharged from a previous hospitalization.

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Official study title

Factors and Experiences Associated with Unscheduled Hospital Readmission After Crenel Lateral Interbody Fusion

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Sep 26, 2024
Registry last updated: Oct 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed